[KD Validated] IL13 Rabbit mAb

[KD Validated] IL13 Rabbit mAb

Seller Gentaur · Catalog number: A23415

Category product: Business and Industry > Scientific and Laboratory Research

 (0) Reviews
Availability: Available
Price

392.96 USD*

Size
200μL
[KD Validated] IL13 Rabbit mAb
[KD Validated] IL13 Rabbit mAb

Catalog number: / Size: / Price : USDtest product-price-currency (VAT free)

Inquiry cart
1
Adres Email: | Edit
2
Details of the inquiry
[KD Validated] IL13 Rabbit mAb
[KD Validated] IL13 Rabbit mAb

Catalog number: A23415 / Size: 200μL / Price: 392.96 USD (VAT free)

3
Inquiry cart
* Net price, excluding transport costs. Contact us to receive the current offer within 24 hours.
[KD Validated] IL13 Rabbit pAb
Ask for price
Availability: Out of stock
Cat: A22112
Ask for more info: [email protected]
[KD Validated] IL13 Rabbit pAb
Ask for price
Availability: Out of stock
Cat: MBS9144859-002mL
Ask for more info: [email protected]
[KD Validated] IL13 Rabbit pAb
Ask for price
Availability: Out of stock
Cat: MBS9144859-01mL
Ask for more info: [email protected]
[KD Validated] PSAP Rabbit mAb
Ask for price
Availability: Out of stock
Cat: A22736
Ask for more info: [email protected]
[KD Validated] RAB10 Rabbit mAb
Ask for price
Availability: Out of stock
Cat: A22746
Ask for more info: [email protected]
  • Specifications: Monoclonal Antibodies
  • Storage and shipping: Store at -20℃. Avoid freeze / thaw cycles.|Buffer: PBS with 0.05% proclin300,0.05% BSA,50% glycerol,pH7.3.
  • Notes: Cancer,Tumor immunology,Immunology Inflammation,Cytokines,Interleukins,Cell Intrinsic Innate Immunity Signaling Pathway
  • Additional information: This gene is a member of the alpha interferon gene cluster on chromosome 9. The encoded cytokine is a member of the type I interferon family that is produced in response to viral infection as a key part of the innate immune response with potent antiviral, antiproliferative and immunomodulatory properties. This cytokine, like other type I interferons, binds a plasma membrane receptor made of IFNAR1 and IFNAR2 that is ubiquitously expressed, and thus is able to act on virtually all body cells. The encoded protein is effective in reducing the symptoms and duration of the common cold and in treating many types of cancer, including some hematological malignancies and solid tumors. A deficiency of type I interferon in the blood is thought to be a hallmark of severe COVID-19 and may provide a rationale for a combined therapeutic approach.